Intensifying dialysis: how far should we go and at what cost?

Intensifying dialysis: how far should we go and at what cost?

27. Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008; 74: 613 28. Zhou H, Pisitkun T, Aponte A et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006; 70: 1847 29. Hoorn EJ, Pisitkun T, Zietse R et al. Prospects for urinary proteomics: ex...

Trisomy 18: how far should we go.

Fluctuating asymmetry and animal welfare: how far are we? And how far should we go?

In the associated review, published in this issue of the Journal, Møller and Manning (2003) propose measures of developmental instability, primarily fluctuating asymmetry, for the assessment of animal welfare in agricultural practice. They see the advantages of fluctuating asymmetry in that it provides a single measure of organismal health that ‘‘can be used in all kinds of organisms including ...

Carcinoembryonic antigen screening: how far should we go?

INTRODUCTION The role of carcinoembryonic antigen (CEA) in screening has been previously investigated and found to be inefficient because of its low sensitivity and specificity. Nevertheless, it is still used as a tumour marker in health screening packages, often for asymptomatic patients. We aimed to review all asymptomatic patients who were referred to our department for raised CEA, to determ...

Living donor kidney transplantation: how far should we go?

INTRODUCTION The aim of this review was to describe the work that the Başkent University Faculty of Medicine has done to increase kidney donors' number in Turkey and also to discuss the major effects that donor-organ shortage is currently having worldwide. MATERIALS AND METHODS From 1975 through 2003, our transplantation team at Hacettepe University Hospital and later at the Başkent Universit...